Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 759 of 6351
-
Goji berry trial hopes to shield aging eyes from vision loss
Prevention Recruiting nowThe goal of this project is to conduct a clinical trial in 60 participants ranging from age 65-95 who are at risk for age-related macular degeneration (AMD). The study will evaluate the effects of 14g of goji berry intake or an equivalent amount and type of fiber, five days a wee…
Sponsor: University of California, Davis • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
Intensive weight loss program aims to transform care for severe obesity
Disease control OngoingIn this trial, the aim is to assess the clinical benefits and harms, as well as cost-effectiveness of an intensive weight loss (IWL) intervention that includes total dietary replacements, behavioural support and weight-loss medication compared with existing weight management prog…
Sponsor: Carsten Dirksen • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New gene therapy trial hopes to tame rare metabolic disease in kids
Disease control Recruiting nowPhase I, open-label, single-arm, single-dose, trial of VGM-R02b (gene replacement therapy) in patients with Glutaric Acidemia Type I (GA-I) who meet enrollment criteria and are genetically confirmed by GCDH gene mutation. 1 to 3 patients aged≤ 6 years at the time of screening wil…
Phase 1 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Promising drug cocktail targets Hard-to-Treat ovarian cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether the combination of avutometinib, defactinib, and letrozole is an effective treatment for people with low-grade serous ovarian cancer (LGSOC). The researchers will also look at the safety of this combination.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Fresh donor cells take on childhood leukemia in early trial
Disease control Recruiting nowThis is a phase I, open label study to evaluate the safety, identify the recommended dose (RD) and obtain preliminar evidence of the efficacy of allogeneic, CD19-directed Chimeric Antigen Receptor T (alloCAR-T) cells in pediatric and young adults patients with relapsed/refractory…
Phase 1 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Exercise may help immune cells attack oesophageal tumors
Knowledge-focused Recruiting nowBackground Regular exercise can significantly improve physical and mental health during cancer treatment and reduce the time needed in the hospital. Animal studies suggest that exercise training can also reduce the number of cancer cells. For example, exercise training in mice p…
Sponsor: University of Surrey • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New hope for kids with hemophilia: can SCT800 stop bleeds before they start?
Disease control Recruiting nowThis is an Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.
Phase 3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for SMA babies: risdiplam trial launches in newborns
Disease control CompletedThis study will evaluate the pharmacokinetics (PK) and safety of risdiplam in participants with spinal muscular atrophy (SMA) under 20 days of age at first dose.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a simple chest strap replace invasive heart tests?
Diagnosis Recruiting nowPulmonary hypertension is a serious and progressive disease that is difficult to treat and diagnose, mainly because its symptoms are nonspecific and often delay recognition. Early diagnosis is a major challenge. Although several tests may suggest the disease, the definitive diagn…
Sponsor: University of Sao Paulo General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:11 UTC
-
New eczema cream shows promise in large trial
Symptom relief CompletedThis study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or are intolerant to, or contraindicated to topical corticosteroid (TCS)s and topical calcineurin inhibitor (TCI)s.
Phase 3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New study tests if fewer radiation sessions can match standard prostate cancer treatment
Disease control Recruiting nowThis study is being done to answer the following question: Is the strategy to give higher doses of radiotherapy treatment over a shorter period of time using special equipment and fewer treatments (also known as Stereotactic Body Radiation Therapy or SBRT) as effective as usual e…
Phase 3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New CAR-T therapy aims to tackle Hard-to-Treat hodgkin lymphoma
Disease control Recruiting nowDespite the progress in the therapy, Hodgkin's Lymphoma (HL) remains fatal for more than 15% of patients. Even in patients who are cured, the morbidity of therapy is substantial and long-lasting. New therapeutic agents are required therefore not only to further reduce mortality b…
Phase 1/2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heart stent showdown: FFR vs. angiography for major artery blockage
Disease control Recruiting nowThe primary purpose of the study was to determine whether the 2-year probability of major adverse cardiac events (primary composite outcome) differed significantly between patients who underwent angiography-guided Percutaneous Coronary Intervention(PCI) and those who underwent Fr…
Sponsor: Seung-Jung Park • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to tackle recurrent brain lymphomas
Disease control Recruiting nowThis study is being conducted to evaluate the safety and efficacy of the combination of pemetrexed and zanubrutinib (called induction therapy) followed by zanubrutinib treatment alone (also called maintenance therapy) in people who have relapsed or refractory (RR) primary central…
Phase 2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Cancer-Killing virus combined with keytruda shows promise in stubborn tumors
Disease control Recruiting nowThe goal of this study is to learn about of the research study drug, telomelysin (OBP-301), in combination with pembrolizumab in advanced or metastatic gastric or gastroesophageal junction (GEJ) cancer. The main question it aims to answer is whether this combination is safe and e…
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gut bacteria swap could disarm superbugs in hospital patients
Disease control Recruiting nowThe purpose of this study is to better understand the effectiveness and safety of microbiome therapies (MT) as a treatment for patients with Multidrug Resistant Organism (MDRO) colonization after an infection. Limited data from prior studies suggest that MT may be an effective tr…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could an AI-Designed pill take on Hard-to-Treat cancers?
Disease control Recruiting nowThe goal of this clinical trial is to study ISM8207 in participants with advanced solid tumors and relapsed/refractory B-cell lymphoma. The primary objective is to evaluate the safety and tolerability of ISM8207 orally administered in participants with advanced solid tumors and r…
Phase 1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a Two-Drug combo supercharge weight loss?
Disease control CompletedThe main purpose of this study is to determine if combining tirzepatide with mibavademab will result in more weight loss in adult participants than tirzepatide alone. The study will last about 74 weeks and may include up to 19 visits.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Peer power: could support groups boost HIV prevention in transgender men?
Prevention CompletedTransgender masculine and gender diverse people who have sex with men (TMSM) have an increased risk of human immunodeficiency virus (HIV) and face unique barriers engaging in prevention services. Digitally delivered support interventions addressing HIV prevention barriers deliver…
Sponsor: Fenway Community Health • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
Stroke patients may get a second chance with early tirofiban
Disease control Recruiting nowThe purpose of this study is to assess the safety and efficacy of early administration of tirofiban in patients treated with tenecteplase for acute ischemic stroke.
Phase 3 • Sponsor: Second Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC